Profil
Pei Yu Li is an Independent Non-Executive Director at Sinopharm Group Co., Ltd. since 2020 and an Independent Director at BeBetter Med, Inc. since 2021.
Previously, Dr. Li was Chairman at China Reinsurance (Group) Corp.
from 2010 to 2016.
Education includes an undergraduate degree from Tsinghua University in 1984, a graduate degree from John F.
Kennedy School in 1998, and a doctorate from Tsinghua University School of Economics & Management in 2004.
Postes actifs de Pei Yu Li
| Sociétés | Poste | Début |
|---|---|---|
| SINOPHARM GROUP CO. LTD. | Directeur/Membre du Conseil | 18/09/2020 |
| BEBETTER MED INC. | Directeur/Membre du Conseil | 20/12/2021 |
Anciens postes connus de Pei Yu Li
| Sociétés | Poste | Fin |
|---|---|---|
China Reinsurance (Group) Corp.
China Reinsurance (Group) Corp. Multi-Line InsuranceFinance Provides fire, marine and casualty reinsurance services | Président | 11/03/2016 |
Formation de Pei Yu Li
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Sinopharm Group Co., Ltd.
Sinopharm Group Co., Ltd. Medical DistributorsDistribution Services Distributes pharmaceuticals and medical devices & operates retail pharmacies | Distribution Services |
Tsinghua University
Tsinghua University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
China Reinsurance (Group) Corp.
China Reinsurance (Group) Corp. Multi-Line InsuranceFinance Provides fire, marine and casualty reinsurance services | Finance |
John F. Kennedy School
John F. Kennedy School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tsinghua University School of Economics & Management
Tsinghua University School of Economics & Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BeBetter Med, Inc.
BeBetter Med, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company and develops drugs for oncology, autoimmune and metabolic diseases | Health Technology |
















